Pulse Biosciences, Inc., a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced U.S. Food and Drug Administration (FDA) clearance of the CellFX® System for dermatologic procedures requiring ablation

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In